PGP and hepatocellular carcinoma: In hepatocellular carcinoma cells expressing mutp53 (R248Q), dihydroartemisinin can reduce P-gp expression and restore DOX sensitivity by inhibiting the p53/ERK1/2/NF-κB signaling pathway [63].